# Elucidating the mechanistic association of xylene inducing non-small cell lung cancer through network toxicology and molecular docking analysis

**Authors:** Hongquan Chen, Xiangpeng Chen, Weibin Lin, Qing Chen, Renxi Lin, Mingfang Zhang, Yuanlin Qi, Tsai-Ching Hsu, Tsai-Ching Hsu, Tsai-Ching Hsu

PMC · DOI: 10.1371/journal.pone.0341548 · PLOS One · 2026-03-13

## TL;DR

This study explores how xylene exposure may lead to non-small cell lung cancer by analyzing gene targets and signaling pathways.

## Contribution

The study introduces a novel combination of network toxicology and molecular docking to elucidate xylene's role in NSCLC.

## Key findings

- Xylene isomers show strong binding to proteins linked to cancer pathways like PI3K-Akt and focal adhesion.
- Key target genes (IL1A, H3C13, ITGAM, CCR5, COMT) are primarily expressed in immune cells.
- Network analysis reveals xylene's potential to disrupt cellular signals and promote tumor growth.

## Abstract

Xylene is a common industrial solvent that includes three isomers: o-xylene, m-xylene, and p-xylene. Long-term exposure to low doses of xylene in the environment has been linked to a higher risk of lung cancer. However, the molecular mechanisms behind this link are still not fully understood. In this study, we used a combination of network toxicology and molecular docking to investigate how xylene may contribute to the development of non-small cell lung cancer (NSCLC). We first identified 115 potential target genes related to xylene exposure by searching several public databases, including CHEMBL, STITCH, GeneCards, and OMIM. Further screening using the STRING platform and Cytoscape analysis highlighted five core targets: IL1A, H3C13, ITGAM, CCR5, and COMT. We utilized scRNA-seq data to analyze the expression patterns of core targets across distinct cell subpopulations, the majority of core targets were expressed in immune cells. We then performed GO and KEGG pathway enrichment analysis. These results showed that the five target genes are mainly involved in cancer-related pathways, such as ECM-receptor interaction, focal adhesion, chemical carcinogenesis, and the PI3K-Akt signaling pathway. Molecular docking results confirmed that xylene isomers have strong binding affinities with the proteins encoded by these genes. This suggests that xylene may disrupt important cellular signals and promote tumor growth. In conclusion, our study provides new insight into how xylene might cause NSCLC at the molecular level. It also shows the usefulness of network toxicology in evaluating health risks from environmental chemicals. These findings may help guide future efforts in prevention and treatment strategies.

## Linked entities

- **Genes:** IL1A (interleukin 1 alpha) [NCBI Gene 3552], H3C13 (H3 clustered histone 13) [NCBI Gene 653604], ITGAM (integrin subunit alpha M) [NCBI Gene 3684], CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234], COMT (catechol-O-methyltransferase) [NCBI Gene 1312]
- **Chemicals:** o-xylene (PubChem CID 7237), m-xylene (PubChem CID 7929), p-xylene (PubChem CID 7809)
- **Diseases:** non-small cell lung cancer (MONDO:0005233), lung cancer (MONDO:0005138)

## Full-text entities

- **Genes:** CD3D (CD3 delta subunit of T-cell receptor complex) [NCBI Gene 915] {aka CD3-DELTA, CD3DELTA, IMD19, T3D}, COMT (catechol-O-methyltransferase) [NCBI Gene 1312] {aka HEL-S-98n}, CD3G (CD3 gamma subunit of T-cell receptor complex) [NCBI Gene 917] {aka CD3-GAMMA, CD3GAMMA, IMD17, T3G}, C1QB (complement C1q B chain) [NCBI Gene 713] {aka C1QD2}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, LYZ (lysozyme) [NCBI Gene 4069] {aka AMYLD5, LYZF1, LZM}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, CCN2 (cellular communication network factor 2) [NCBI Gene 1490] {aka CTGF, HCS24, IBP-8, IGFBP8, KMD, NOV2}, VWF (von Willebrand factor) [NCBI Gene 7450] {aka F8VWF, VWD}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, CD248 (CD248 molecule) [NCBI Gene 57124] {aka CD164L1, TEM1}, DCN (decorin) [NCBI Gene 1634] {aka CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B}, C1QA (complement C1q A chain) [NCBI Gene 712] {aka C1QD1}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, TPSB2 (tryptase beta 2) [NCBI Gene 64499] {aka TPS2, tryptaseB, tryptaseC}, CD79B (CD79b molecule) [NCBI Gene 974] {aka AGM6, B29, IGB, Igbeta}, KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, APOC1 (apolipoprotein C1) [NCBI Gene 341] {aka APOC1B, Apo-CI, ApoC-I, apo-CIB, apoC-IB}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, KRT18 (keratin 18) [NCBI Gene 3875] {aka CK-18, CYK18, K18}, TPSAB1 (tryptase alpha/beta 1) [NCBI Gene 7177] {aka TPS1, TPS2, TPSB1, TPSB2, Tryptase-2}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, PECAM1 (platelet and endothelial cell adhesion molecule 1) [NCBI Gene 5175] {aka CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM}, CD34 (CD34 molecule) [NCBI Gene 947], PLVAP (plasmalemma vesicle associated protein) [NCBI Gene 83483] {aka DIAR10, FELS, PV-1, PV1, gp68}, IGHM (immunoglobulin heavy constant mu) [NCBI Gene 3507] {aka AGM1, MU, VH}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, CCR5 (C-C motif chemokine receptor 5) [NCBI Gene 1234] {aka CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5}, NKG7 (natural killer cell granule protein 7) [NCBI Gene 4818] {aka GIG1, GMP-17, p15-TIA-1}, DOCK2 (dedicator of cytokinesis 2) [NCBI Gene 1794] {aka IMD40}, FCN1 (ficolin 1) [NCBI Gene 2219] {aka FCNM}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, C1QC (complement C1q C chain) [NCBI Gene 714] {aka C1Q-C, C1QD3, C1QG}, CD3E (CD3 epsilon subunit of T-cell receptor complex) [NCBI Gene 916] {aka CD3epsilon, IMD18, T3E, TCRE}, CD14 (CD14 molecule) [NCBI Gene 929], PDGFRA (platelet derived growth factor receptor alpha) [NCBI Gene 5156] {aka CD140A, PDGFR-2, PDGFR2}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, LUM (lumican) [NCBI Gene 4060] {aka LDC, SLRR2D}, CPA3 (carboxypeptidase A3) [NCBI Gene 1359] {aka MC-CPA}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, MS4A1 (membrane spanning 4-domains A1) [NCBI Gene 931] {aka B1, Bp35, CD20, CVID5, FMC7, LEU-16}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, ACTA2 (actin alpha 2, smooth muscle) [NCBI Gene 59] {aka ACTSA, SMDYS}
- **Diseases:** irritation of the eyes, nose, and throat (MESH:D009669), large cell carcinoma (MESH:D018287), NSCLC (MESH:D002289), system (MESH:D015619), toxicity (MESH:D064420), cardiovascular disorders (MESH:D002318), Lung cancer (MESH:D008175), carcinogenesis (MESH:D063646), lung, thyroid, prostate, and other common cancers (MESH:D011471), metastasis (MESH:D009362), adenocarcinoma (MESH:D000230), inflammatory (MESH:D007249), carcinogenic (MESH:D011230), LUSC (MESH:D002294), Cancer (MESH:D009369), LUAD (MESH:D000077192)
- **Chemicals:** lipid (MESH:D008055), Xylene (MESH:D014992), m-xylene (MESH:C031285), TRIzol (MESH:C411644), asbestos (MESH:D001194), SYBR Green (MESH:C098022), toluene (MESH:D014050), catecholamine (MESH:D002395), carbon (MESH:D002244), VOCs (MESH:D055549), Benzene (MESH:D001554), BTX (-), hydrogen (MESH:D006859), water (MESH:D014867), CO2 (MESH:D002245), polycyclic aromatic hydrocarbons (MESH:D011084), catechol (MESH:C034221), ethylbenzene (MESH:C004912), p-xylene (MESH:C031286), o-xylene (MESH:C026114)
- **Species:** Nicotiana tabacum (American tobacco, species) [taxon 4097], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs4680, rs1799987
- **Cell lines:** PC9 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_B260), Hsu — Culex quinquefasciatus (Southern house mosquito), Spontaneously immortalized cell line (CVCL_B3N4), H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), Beas-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12987433/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12987433/full.md

## References

42 references — full list in the complete paper: https://tomesphere.com/paper/PMC12987433/full.md

---
Source: https://tomesphere.com/paper/PMC12987433